Processa pharmaceuticals to present an update on its future therapeutic focus and strategy at the biotech showcase on january 11, 2023.

Hanover, md, jan. 04, 2023 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa), dr. david young, processa pharmaceuticals, ceo will present an update on processa's future therapeutic focus and strategy at the upcoming biotech showcase on january 11, 2023, at 10 am. this presentation will also be accessible at https://event.webcasts.com/starthere.jsp?ei=1591773&tp_key=fbb2da9fa8
PCSA Ratings Summary
PCSA Quant Ranking